PATENT CLAIM ANALYSIS

Application Number: 15977772
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "300000"]

Abstract:
Provided herein are heterocyclic compounds of Formula (I), pharmaceutical compositions containing such a compound and their therapeutic uses, methods for their preparation, intermediate compounds, pharmaceutical compositions containing such a compound, and their therapeutic uses.

Claim (Index 13):
The method of  claim 12 , wherein the one or more additional therapeutic agents is an epigenetic modulator selected from the group consisting of:\n (a) a DNA methyltransferase; (b) a histone or protein methyltransferase; (c) a histone demethylase; (d) a histone deacetylase inhibitor; (e) histone acetyltransferase; and (f) other chromatin remodelers.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.61538
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15689931', '15269054', '13403394', '15160729', '15654538']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7760049381264638
- 35 USC 102 Novelty (BERT): 0.5866356433019739
- Combined Prediction Score: 0.7570680086440148
- Mean Citation Score: 358.29446
- Max Citation Score: 491.654
- Similarity Product: 424.1485213445425

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test